KAPA

Kairos Pharma, Ltd.

1.71 USD

Last updated Sep 12, 02:10 UTC

Yesterday HIGH

$1.73

Yesterday LOW

$1.62

52w HIGH

$14.77

52w LOW

$1.51

EPS

-2.94

PE

-0.58

Next Earnings

Nov 13, 2026

Overview News Government Trades Fundamentals

Kairos Pharma, Ltd. stock is down -32.14% since 30 days ago. The next earnings date is Nov 13, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 2 September’s closed higher than August.

Benzinga Newsdesk

Fri Aug 21, 2026

Kairos Pharma Announces 1-For-7 Reverse Stock Split, Effective Sept. 1

Kairos Pharma, Ltd. (NYSE:KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced that it will conduct a reverse stock split of its outstanding shares of common
Benzinga Insights

Wed Jul 22, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million. Medpace Holdings
Benzinga Newsdesk

Wed Jul 22, 2026

Kairos Pharma shares are trading lower. The company announced a collaboration with Bayer to evaluate ENV-105 with XOFIGO in metastatic castration-resistant prostate cancer involving bone.
Benzinga Newsdesk

Wed Jul 22, 2026

Kairos Pharma Partners With Bayer To Mull ENV-105 Inhibitor In Combination With Bayer’s XOFIGO

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced a strategic collaboration with Bayer to evaluate Kairos Pharma’s lead
Benzinga Insights

Fri Jul 17, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market session. The market value of their outstanding shares is at $112.9 million. Barinthus Biotherapeutics (NASDAQ:BRNS)
Benzinga Insights

Thu Jul 16, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 billion. Agape ATP (NASDAQ:ATPC) shares moved upwards by
Avi Kapoor

Thu Jul 16, 2026

Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7.9% in pre-market trading. Other top gainers include ATPC, TGHL, ATAI, DXST, KAPA, EHGO, HELP, VSA, and CMPS.
Mohd Haider

Thu Jul 16, 2026

Kairos Pharma (KAPA) Stock Surges Over 22% After Hours: Why is it Moving?

Kairos Pharma shares surged 22.64% after hours following positive interim safety data from its lead cancer drug candidate ENV-105.
Benzinga Newsdesk

Wed Jul 15, 2026

Kairos Pharma Announces Interim Safety Data From Phase I Trial Of Carotuximab In Combination With AstraZeneca's Osimertinib To Resensitize Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer Who Became Resistant To Osimertinib
Benzinga Insights

Fri May 1, 2026

12 Health Care Stocks Moving In Friday's After-Market Session